Skip to main
CNXC

CNXC Stock Forecast & Price Target

CNXC Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Concentrix is expected to continue gaining market share and wallet share in their high growth verticals, which will lead to increased revenue growth in fiscal 2026. Despite recent acquisition-related expenses and loss on held for sale, investors are pricing in a worst-case scenario, making the risk/reward balance favorable for investing. Additionally, macro and reputation risks should be considered but are unlikely to significantly impact the company's strong earnings outlook.

Bears say

Concentrix is heavily dependent on a limited number of clients, with the top five customers accounting for about 25% of its revenue. Additionally, the company's future growth is heavily reliant on its ability to execute its strategy of transitioning towards a more technology-focused business model, which may be challenging. The company has also experienced some customer concentration in the healthcare industry due to reduced Affordable Care Act participation among key clients. These factors, combined with the company's current valuation, lead to a negative outlook on the stock.

CNXC has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Concentrix Corporation and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Concentrix Corporation (CNXC) Forecast

Analysts have given CNXC a Buy based on their latest research and market trends.

According to 4 analysts, CNXC has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $48.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $48.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Concentrix Corporation (CNXC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.